• search
CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
CDMO/CRO Services CDMO/CRO Services

CDMO/CRO Services

Aurigene Pharmaceutical Services provides a wide range of drug discovery, development and manufacturing Services.

Aurigene Pharmaceutical Services provides a flexible and wide range of services and capabilities at each phase of drug lifecycle.

  • End-to-end services across the drug lifecycle.
  • Integrated services and resources enabling seamless and accelerated development from discovery to commercialization.
  • Capabilities to supply from gram scale to multi-ton scale of active ingredients and complex intermediates.
  • Core areas of competence in specialized chemistry (peptides, carbohydrates, steroids, mPEGs).
  • Standalone and integrated discovery services.
  • World-class infrastructure: State-of-the-art R and D and manufacturing facilities audited by major international regulatory agencies.
  • Biotherapeutic modalities including proteins, antibodies, ADCs, CAR Ts, mRNAs.
  • Drug product capabilities from formulation development to commercial production in GMP facilities.
  • Hit Generation

  • Lead    

  • Lead     

  • Early stage drug discovery accelerating innovations for small and large molecules.
  • FTE/FFS services in medicinal chemistry, computational chemistry, discovery biology. and large molecule modalities.
  • Development   
    Phase 1

  • Development:   
    Phase 2

  • Development:   
    Phase 3

  • Helping our partners to bring their innovations to the market faster through phase appropriate development services.
  • Process development and non-GMP supplies and technology transfer.
  • GMP clinical supplies for API and drug product.


  • Ensuring a sustainable supply of APIs and finished formulations.
  • Continuous improvement and reliable commercial supplies from 8 US FDA inspected facilities.

Range of our services

Aurigene Pharmaceutical Services offers end-to-end capabilities across drug discovery, development and manufacturing of APIs and formulations. We have discovery, development and manufacturing operations in multiple technology platforms including carbohydrates, steroids, PEG derivatives, oligonucleotides, steroids, high-potent APIs and peptides. In addition, we run discovery scale and CDMO scale operations in biotherapeutics services such as ADCs, mAbs, mRNAs and CAR Ts.

Aurigene Pharmaceutical Services CRO/CDMO



Discovery Chemistry

Library Synthesis, Peptide Synthesis, PROTAC Synthesis, Oligonucleotide synthesis

Discovery Biology
CADD and Informatics

Development Specialized Chemistry

Peptides High-potent, mPEGs, Carbohydrates, Steroids

Large Molecules  

Discovery Therapeutic Modalities

Monoclonal Antibody (mAb), Antibody Drug Conjugate (ADC), mRNA, Viral vectors, Cell Therapy

Development and Manufacturing

Monoclonal antibody        
Protein therapeutics        


Formulation Services

Eartly phase formulation development, Preformulation, Drug product characterization studies and testing, Pharmaceutical stability studies

Dosage Forms and Integrated DS-DP

Why Aurigene Pharmaceutical Services?

Our focus on scientific expertise and integrated services along with our strong fundamentals on quality infrastructure, sustainability operations, and information security makes us a preferred partner.

icon Truly integrated services

We offer one-stop solutions for

  • Integrated Discovery chemistry and Biology services
  • Small molecule and Large molecule services
  • Services from early discovery to commercialization
  • Global regulatory and quality expertise
  • Pre-formulation and formulation service
  • Analytical and purification expertise

icon Quality

  • Our R and D site is US FDA inspected cGMP sites have multiple accreditations across globe, All our labs are GLP approved, animal facilities are AAALAC accredited

icon Science

  • Strong technology platforms Niche/Sensitive/Complex chemistry expertise

icon Infrastructure

  • 2 R and D centers, 8 US FDA inspected cGMP sites, AAALAC accredited vivarium

icon Information Security

  • 360-degree information security coverage with adequate back-up plan, business continuity plan and information security interventions

icon Business Continuity

  • Structured assurance and governance measures

icon People

  • We strive to hire the best talent and train them,        
    700+ scientists, >95% of scientists are post-graduates or above

icon ESG

  • Commitment to highest standards of Environment, Social and Governance; Dow Jones, CDP, PSCI, approved

Contact Us

CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
“Bathtub Chemistry” - Necessity and Aspects of Process Research

MAY 19, 2023

“Bathtub Chemistry” - Necessity and Aspects of Process Research

Medicine is an essential part of our life. Since ancient time human civilization has been tirelessly engaged to understand the cause and effect of a disease. Sometimes they win and many times they loss. But the story of their curiosity and enthusiasm is a never damping process. On the contrary it increases day by day, year after year.    &nbsp...

Read More

Building successful long-term partnerships with CDMOs from early drug discovery through commercialization

 Maximizing efficiency in drug research, development, and manufacturing is crucial for turning new innovations into therapeutic and financial benefits. Over the past couple of decades, pharmaceutical companies have increasingly turned to contract development and manufacturing organizations (CDMOs) for collaborations as they seek more adaptable capacity and c...

Read More

How the re-designed synthesis of a complex carbohydrate can reduce cycle time

Project challenge: Complex carbohydrate chemistry involving a linear sequence of 10 chemical transformations, unstable intermediates and column chromatographic purications. Solution design: Process research and optimization was performed to develop a robust and scalable process which was implemented on commercial scale. Telescoping of reactions reduced the number...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug


Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.